Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$150,000.00

The in situ mechanism of calcium sensitization by cardiovascular drugs that target troponin

EF 2012-13

Résumé
The heart is the cornerstone of life; for most of our lives it relentlessly drives blood throughout our bodies, keeping us alive by supplying our cells with oxygen and nutrients. Considering its life-sustaining role, it is not surprising that the heart's failure carries grim consequences. Heart failure is defined as the inability of the heart to sufficiently supply the body with blood. Although there are a number of drugs that have proven to be effective for heart failure's short-term treatment, no lasting solution has been identified: approximately half of all people with heart failure will die within 5 years of diagnosis. A unique treatment that carries promise is the pharmacological improvement of heart function by enhancing the muscle directly. Heart muscle contracts when calcium binds to the protein troponin, and drugs that strengthen contraction by increasing troponin's sensitivity to calcium are termed "calcium sensitizers". Despite their obvious therapeutic potential, surprisingly little is understood about how these drugs function. In the proposed research we will examine the molecular mechanism of these compounds. We have synthesized a panel of small molecules that will be tested for their influence on muscle contraction. We will also monitor how these and other calcium sensitizers affect the structure of troponin in cardiac muscle. The results will help us formulate a chemical and structural basis for how these molecules increase the calcium sensitivity of troponin; insights that will provide a firm basis for the development of new, more effective, calcium sensitizers.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
269630
Name
Robertson Ian M
Country
United Kingdom
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
The in situ mechanism of calcium sensitization by cardiovascular drugs that target troponin
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Calcium Sensitizers; Drug Design; Fluorescence Spectroscopy; Heart Failure; In Situ Protein Structure; Muscle Physiology; Thin Filament; Troponin
Abstract
The heart is the cornerstone of life; for most of our lives it relentlessly drives blood throughout our bodies, keeping us alive by supplying our cells with oxygen and nutrients. Considering its life-sustaining role, it is not surprising that the heart's failure carries grim consequences. Heart failure is defined as the inability of the heart to sufficiently supply the body with blood. Although there are a number of drugs that have proven to be effective for heart failure's short-term treatment, no lasting solution has been identified: approximately half of all people with heart failure will die within 5 years of diagnosis. A unique treatment that carries promise is the pharmacological improvement of heart function by enhancing the muscle directly. Heart muscle contracts when calcium binds to the protein troponin, and drugs that strengthen contraction by increasing troponin's sensitivity to calcium are termed "calcium sensitizers". Despite their obvious therapeutic potential, surprisingly little is understood about how these drugs function. In the proposed research we will examine the molecular mechanism of these compounds. We have synthesized a panel of small molecules that will be tested for their influence on muscle contraction. We will also monitor how these and other calcium sensitizers affect the structure of troponin in cardiac muscle. The results will help us formulate a chemical and structural basis for how these molecules increase the calcium sensitivity of troponin; insights that will provide a firm basis for the development of new, more effective, calcium sensitizers.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Robertson, Ian M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~